2016
DOI: 10.1210/jc.2016-1594
|View full text |Cite
|
Sign up to set email alerts
|

Wnt Signaling Genes in Adipose Tissue and Skeletal Muscle of Humans With Different Degrees of Insulin Sensitivity

Abstract: The association of β-catenin-dependent Wnt signaling with insulin resistance is tissue specific. Observed changes might reflect a compensatory mechanism to increase muscle glucose uptake and to generate new fat cells in insulin-resistant conditions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
44
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(49 citation statements)
references
References 34 publications
3
44
0
Order By: Relevance
“…Whether these alterations in the Wnt pathway are congenital or possibly induced by increased sclerostin levels later in life, remains to be explored. Interestingly, Karczewska-Kupczewska et al [33] also previously showed in an euglycemic clamp study that expression of various Wnt signaling genes in WAT was lower in nondiabetic individuals with low versus high insulin sensitivity. Indeed, in our study expression of key insulin genes (INSR, TBC1D4, SLC2A4, and GYS1) in WAT was also lower in South Asians compared with white Caucasians, suggesting that Wnt and insulin signaling in WAT are associated and that lower Wnt signaling might partially reduce insulin signaling in South Asians.…”
Section: Discussionmentioning
confidence: 91%
“…Whether these alterations in the Wnt pathway are congenital or possibly induced by increased sclerostin levels later in life, remains to be explored. Interestingly, Karczewska-Kupczewska et al [33] also previously showed in an euglycemic clamp study that expression of various Wnt signaling genes in WAT was lower in nondiabetic individuals with low versus high insulin sensitivity. Indeed, in our study expression of key insulin genes (INSR, TBC1D4, SLC2A4, and GYS1) in WAT was also lower in South Asians compared with white Caucasians, suggesting that Wnt and insulin signaling in WAT are associated and that lower Wnt signaling might partially reduce insulin signaling in South Asians.…”
Section: Discussionmentioning
confidence: 91%
“…Sclerostin influences SCI-induced bone loss, as evidenced by (1) increased sclerostin mRNA expression in bone acutely after SCI [ 7 ], (2) mice with sclerostin gene deletion that do not exhibit bone loss after spinal cord transection [ 9 ], and (3) the ability pharmacologic sclerostin-inhibition to completely prevent cancellous bone loss in rats following SCI [ 2 , 10 ]. Others have suggested that sclerostin may also influence skeletal muscle [ 5 ], a supposition that is strengthened by the understanding that sclerostin is present in the circulation [ 8 ], that LRP5/LRP6 are expressed in human muscle [ 11 , 12 ], and that the Wnt/β-catenin signaling pathway is anabolic in muscle [ 3 ]. Interestingly, Huang et al recently reported that Wnt3a, an osteocyte-derived Wnt-signaling agonist, promoted C2C12 cell differentiation in vitro and that sclerostin co-incubation (100 ng/ml) prevented this effect [ 13 ], demonstrating that sclerostin negatively regulates Wnt-signaling in a mouse skeletal muscle cell line, at least when present in relatively high concentrations.…”
Section: Introductionmentioning
confidence: 99%
“…MyoD1 is able to promote the transformation of multipotent stem cells to skeletal muscle by binding and activating the expression of a subset of pre-myogenic mesoderm genes, including Six1 [52]. And gene Ctnnb1 modulates skeletal muscle development by acting on transcription factors controlling myogenesis such as MyoD [53].…”
Section: Rna-seq Data Validationmentioning
confidence: 99%